Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research  How it helps Latest publication
RBD-16GS-I53-50
Potential treatment - pre-clinical evidence Experimental Vaccine Oct/30/2020
rbIFN-λ
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/03/2020
BC 007
Potential treatment - pre-clinical evidence Experimental Antiviral Oct/31/2020
Propolis alcohol extract
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/07/2020
RBD-12GS-I53-50
Potential treatment - pre-clinical evidence Experimental Vaccine Oct/30/2020
mRBD
Potential treatment - pre-clinical evidence Experimental Vaccine Nov/23/2020
mNb6-tri
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/05/2020
CTC-445.2d
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/05/2020
CTC-445.2
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/05/2020
2-(3-(3-Chloro-4-fluorobenzoyl)-7-fluoro-4-hydroxy-1,1-dioxido-2H-benzo[e][1,2]thiazin-2-yl)-N-(4-(trifluoromethyl)phenyl)acetamide
Potential treatment - theoretical effect Experimental Antiviral Nov/04/2020
1-((1R)-1-(Hydroxymethyl)-3-(1-naphthyl)propyl)-1H-imidazole-4-carboxamide
Potential treatment - theoretical effect Experimental Antiviral Jan/05/2021
Gallium maltolate
Potential treatment - pre-clinical evidence Experimental Antiviral Dec/22/2020
1-[(1R)-3-(6-{[(Benzylamino)carbonyl]amino}-1H-indol-1-YL)-1-(hydroxymethyl)propyl]-1H-imidazole-4-carboxamide
Potential treatment - theoretical effect Experimental Antiviral Jan/05/2021
1,3,6-trihydroxy-2-methyl-9,10-anthraquinone-3-O-(6′-O-acetyl)-β-D-xylopyranosyl-(1 → 2)-β-D-glucopyranoside
Potential treatment - theoretical effect Experimental Antiviral Aug/08/2020
Nb21
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/05/2020
Nb213
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/05/2020
Nb203
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/05/2020
ZINC15275997
Potential treatment - theoretical effect Experimental Antiviral Jul/31/2020
P2B-1A1
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/17/2021
Etoposide
Potential treatment - theoretical effect Experimental Antiviral Jul/31/2020